PI
PCRX icon

PineBridge Investments’s Pacira BioSciences PCRX Stock Holding History

PineBridge Investments’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-408
Closed -$16.3K – 900
2023
Q2 		$16.3K Buy
+408
New +$16.9K ﹤0.01% 831
2020
Q1 		– Sell
-22,049
Closed -$999K – 956
2019
Q4 		$999K Buy
+22,049
New +$936K 0.02% 578

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

PineBridge Investments's PCRX Position: Q3 2023 in Review

PineBridge Investments sold out of Pacira BioSciences (PCRX) in Q3 2023, closing a stake of 408 shares — an estimated $16.3K sold.

PineBridge Investments first reported a position in PCRX in Q4 2019 and held it in 2 quarters. The position peaked at $999K in Q4 2019. 261 funds tracked by Wall St. Rank hold PCRX as of Q3 2023.

  • PineBridge Investments reported no remaining Pacira BioSciences position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 408 Pacira BioSciences shares in Q3 2023, an estimated $16.3K.
  • PineBridge Investments first reported a position in Pacira BioSciences in Q4 2019 and held it in 2 quarters.
  • PineBridge Investments's Pacira BioSciences position peaked at $999K in Q4 2019.
  • 261 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.